286 related articles for article (PubMed ID: 21438934)
1. Methamphetamine users show greater than normal age-related cortical gray matter loss.
Nakama H; Chang L; Fein G; Shimotsu R; Jiang CS; Ernst T
Addiction; 2011 Aug; 106(8):1474-83. PubMed ID: 21438934
[TBL] [Abstract][Full Text] [Related]
2. Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine.
Morales AM; Lee B; Hellemann G; O'Neill J; London ED
Drug Alcohol Depend; 2012 Oct; 125(3):230-8. PubMed ID: 22445480
[TBL] [Abstract][Full Text] [Related]
3. Decreased frontal lobe phosphocreatine levels in methamphetamine users.
Sung YH; Yurgelun-Todd DA; Shi XF; Kondo DG; Lundberg KJ; McGlade EC; Hellem TL; Huber RS; Fiedler KK; Harrell RE; Nickerson BR; Kim SE; Jeong EK; Renshaw PF
Drug Alcohol Depend; 2013 Apr; 129(1-2):102-9. PubMed ID: 23084413
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in impulsivity and brain morphometry in methamphetamine users.
Kogachi S; Chang L; Alicata D; Cunningham E; Ernst T
Brain Struct Funct; 2017 Jan; 222(1):215-227. PubMed ID: 27095357
[TBL] [Abstract][Full Text] [Related]
5. Structural abnormalities in the brains of human subjects who use methamphetamine.
Thompson PM; Hayashi KM; Simon SL; Geaga JA; Hong MS; Sui Y; Lee JY; Toga AW; Ling W; London ED
J Neurosci; 2004 Jun; 24(26):6028-36. PubMed ID: 15229250
[TBL] [Abstract][Full Text] [Related]
6. Impact of methamphetamine on regional metabolism and cerebral blood flow after traumatic brain injury.
O'Phelan K; Ernst T; Park D; Stenger A; Denny K; Green D; Chang C; Chang L
Neurocrit Care; 2013 Oct; 19(2):183-91. PubMed ID: 23836426
[TBL] [Abstract][Full Text] [Related]
7. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response.
Chang L; Cloak C; Patterson K; Grob C; Miller EN; Ernst T
Biol Psychiatry; 2005 May; 57(9):967-74. PubMed ID: 15860336
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.
Dean AC; Nurmi EL; Morales AM; Cho AK; Seaman LC; London ED
Addict Biol; 2021 May; 26(3):e12950. PubMed ID: 32767519
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use.
Ernst T; Chang L
J Neuroimmune Pharmacol; 2008 Sep; 3(3):165-72. PubMed ID: 18521756
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric symptoms and HPA axis function in adolescent methamphetamine users.
King G; Alicata D; Cloak C; Chang L
J Neuroimmune Pharmacol; 2010 Dec; 5(4):582-91. PubMed ID: 20358305
[TBL] [Abstract][Full Text] [Related]
11. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
Taylor MJ; Schweinsburg BC; Alhassoon OM; Gongvatana A; Brown GG; Young-Casey C; Letendre SL; Grant I;
J Neurovirol; 2007 Apr; 13(2):150-9. PubMed ID: 17505983
[TBL] [Abstract][Full Text] [Related]
12. Gray-matter structure in long-term abstinent methamphetamine users.
Nie L; Zhao Z; Wen X; Luo W; Ju T; Ren A; Wu B; Li J
BMC Psychiatry; 2020 Apr; 20(1):158. PubMed ID: 32272912
[TBL] [Abstract][Full Text] [Related]
13. Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis.
Hall MG; Alhassoon OM; Stern MJ; Wollman SC; Kimmel CL; Perez-Figueroa A; Radua J
Am J Drug Alcohol Abuse; 2015; 41(4):290-9. PubMed ID: 26125488
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.
Lawyer G; Bjerkan PS; Hammarberg A; Jayaram-Lindström N; Franck J; Agartz I
BMC Pharmacol; 2010 May; 10():5. PubMed ID: 20487539
[TBL] [Abstract][Full Text] [Related]
15. Gray matter volume showed dynamic alterations in methamphetamine users at 6 and 12months abstinence: A longitudinal voxel-based morphometry study.
Ruan X; Zhong N; Yang Z; Fan X; Zhuang W; Du J; Jiang H; Zhao M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():350-355. PubMed ID: 28887180
[TBL] [Abstract][Full Text] [Related]
16. Correlates of nonmedical use of stimulants and methamphetamine use in a national sample.
Chen LY; Strain EC; Alexandre PK; Alexander GC; Mojtabai R; Martins SS
Addict Behav; 2014 May; 39(5):829-36. PubMed ID: 24583271
[TBL] [Abstract][Full Text] [Related]
17. N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users.
Tang J; O'Neill J; Alger JR; Shen Z; Johnson MC; London ED
Int J Neuropsychopharmacol; 2019 Jan; 22(1):1-9. PubMed ID: 29788422
[TBL] [Abstract][Full Text] [Related]
18. The Role of Aging, Drug Dependence, and Hepatitis C Comorbidity in Alcoholism Cortical Compromise.
Sullivan EV; Zahr NM; Sassoon SA; Thompson WK; Kwon D; Pohl KM; Pfefferbaum A
JAMA Psychiatry; 2018 May; 75(5):474-483. PubMed ID: 29541774
[TBL] [Abstract][Full Text] [Related]
19. Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users.
Alicata D; Chang L; Cloak C; Abe K; Ernst T
Psychiatry Res; 2009 Oct; 174(1):1-8. PubMed ID: 19782540
[TBL] [Abstract][Full Text] [Related]
20. A qualitative study of methamphetamine initiation among Chinese male users: Patterns and policy implications.
Liu L; Chui WH; Chai X
Int J Drug Policy; 2018 Dec; 62():37-42. PubMed ID: 30359871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
